Adapted Physical Activity for Persistent Fatigue in Patients With Inflammatory Bowel Disease in Remission
cAPAble
Impact of Adapted Physical Activity on Persistent Fatigue in Patients With Inflammatory Bowel Disease in Remission
1 other identifier
interventional
120
1 country
1
Brief Summary
The cAPAble study aims to evaluate the impact of an adapted physical activity program on persistent fatigue in patients with inflammatory bowel disease in remission. This multicenter randomized study will include 120 participants. Participants will be randomly assigned to either a 6-month adapted physical activity program or usual care. Fatigue will be assessed using the FACIT-F questionnaire at 6 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2027
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 31, 2026
CompletedFirst Posted
Study publicly available on registry
September 4, 2026
CompletedStudy Start
First participant enrolled
June 1, 2027
ExpectedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2028
Study Completion
Last participant's last visit for all outcomes
February 1, 2030
September 11, 2026
September 1, 2026
1.5 years
August 31, 2026
September 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) score at 6 months.
Mean Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) score in each study arm at 6 months. The FACIT-F scale ranges from 0 to 52, with higher scores indicating less fatigue and better quality of life.
at 6 months
Secondary Outcomes (16)
Fatigue assessed by the FACIT-Fatigue (FACIT-F) score at 3 and 12 months
At 3 months and 12 months
Quality of life assessed by the Inflammatory Bowel Disease Disability Index (IBD-Disk)
At 3 months, 6 months and 12 months
Physical condition assessed by Body weight
At 6 months and 12 months
Physical condition assessed by body mass index
At 6 months and 12 months
Physical condition assessed by waist circumference
At 6 months and 12 months
- +11 more secondary outcomes
Study Arms (2)
Adapted Physical Activity
EXPERIMENTALA 6-month adapted physical activity program tailored to the participant's individual physical abilities and needs.
Usual Care
OTHERParticipants will receive usual care according to standard clinical practice.
Interventions
A 6-month adapted physical activity program tailored to each participant's physical abilities and individual needs. The program consists of 12 one-hour sessions delivered every two weeks, followed by 2 months of telephone follow-up to support participants in maintaining regular physical activity.
Participants will receive usual care according to standard clinical practice.
Eligibility Criteria
You may qualify if:
- Patients with inflammatory bowel disease (IBD) in clinical and biological remission (CRP/fecal calprotectin) for more than 6 months:
- Remission according to PRO2 (Patient-Reported Outcome): liquid stool frequency ≤2/day and abdominal pain score ≤1 for Crohn's disease; stool frequency score ≤1 and rectal bleeding score = 0 for ulcerative colitis.
- CRP \<5 mg/L.
- Fecal calprotectin \<250 µg/g.
- Adults aged 18 years or older.
- Medical certificate confirming fitness to participate in physical activity. If the participant does not have a recent certificate dated within the previous 3 months, a specific consultation with the treating physician will be required. This consultation will be covered by the sponsor.
You may not qualify if:
- Another identified cause of fatigue based on the first-line assessment performed in this context (complete blood count, liver function tests, CRP, blood electrolyte panel, serum creatinine, iron studies, folate, vitamin B12, TSH, fasting blood glucose).
- Unstable cardiovascular or respiratory disease.
- Current pregnancy or pregnancy planned during the study period.
- Inability, for technical or other reasons, to connect to the Internet for telemonitoring and/or telerehabilitation.
- Planned surgery requiring hospitalization.
- Refusal to participate.
- Persons under legal guardianship or deprived of liberty.
- Uncontrolled diagnosed psychiatric disorder.
- Participant who cannot be contacted in case of an emergency.
- Any surgery planned during the first 6 months of the study that requires hospitalization.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Grenoble Alpes
Grenoble, 38700, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 31, 2026
First Posted
September 4, 2026
Study Start (Estimated)
June 1, 2027
Primary Completion (Estimated)
December 1, 2028
Study Completion (Estimated)
February 1, 2030
Last Updated
September 11, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share